Optical coherence tomography: From research to practice

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 5, 2012, Pages 370-384

  Gutiérrez Chico, Juan Luis ^a   Alegría Barrero, Eduardo ^b   Teijeiro Mestre, Rodrigo ^b   Chan, Pak Hei ^b   Tsujioka, Hiroto ^c   De Silva, Ranil ^b   Viceconte, Nicola ^b   Lindsay, Alistair ^b   Patterson, Tiffany ^b   Foin, Nicolas ^d   Akasaka, Takashi ^c   Di Mario, Carlo ^b,d  

^a UNIVERSITY OF VIGO   (Spain)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apposition; Atherosclerotic plaque; Intimal hyperplasia; Intravascular imaging; Neointima; Optical coherence tomography; Stent

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CARDIAC IMAGING; CLINICAL PRACTICE; CORONARY FLOW RESERVE; CORONARY STENT; DISEASE SEVERITY; HEART INJURY; HUMAN; IMAGE ANALYSIS; INTRACARDIAC THROMBOSIS; MEDICAL DECISION MAKING; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW;

ACUTE CORONARY SYNDROME; BIOMEDICAL RESEARCH; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; NEOINTIMA; SEVERITY OF ILLNESS INDEX; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84863837883     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes025     Document Type: Review

References (97)

1. Spears JR, Sandor T, Als AV, Malagold M, Markis JE, Grossman W et al. Computerized image analysis for quantitative measurement of vessel diameter from cineangiograms. Circulation 1983;68:453-61. (Pubitemid 13028925)
2. Reiber JH, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71: 280-8. (Pubitemid 15157088)
3. Abizaid A, Mintz GS, Pichard AD, Kent KM, Satler LF, Walsh CL et al. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol 1998;82:423-8. (Pubitemid 28389938)
4. Briguori C, Anzuini A, Airoldi F, Gimelli G, Nishida T, Adamian M et al. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol 2001;87:136-41. (Pubitemid 32057220)
5. Nishioka T, Amanullah AM, Luo H, Berglund H, Kim CJ, Nagai T et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999;33:1870-8.
6. Nam CW, Yoon HJ, Cho YK, Park HS, Kim H, Hur SH et al. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided. JACC Cardiovasc Interv 2010;3:812-7.
7. Ahn JM, Kang SJ, Mintz GS, Oh JH, Kim WJ, Lee JY et al. Validation of minimal luminal area measured by intravascular ultrasound for assessment of functionally significant coronary stenosis: comparison with myocardial perfusion imaging. JACC Cardiovasc Interv 2011;4:665-71.
8. Ben-Dor I, Torguson R, Gaglia MA Jr, Gonzalez MA, Maluenda G, Bui AB et al. Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis. EuroIntervention 2011;7:225-33.
9. Bech GJW, De Bruyne B, Pijls NHJ, de Muinck ED, Hoorntje JCA, Escaned J et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001;103:2928-34. (Pubitemid 32578130)
10. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, Veer M et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
11. Gonzalo N, Serruys PW, Garcia-Garcia HM, van Soest G, Okamura T, Ligthart J et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. Rev Esp Cardiol 2009;62:615-24.
12. Kawase Y, Hoshino K, Yoneyama R, McGregor J, Hajjar RJ, Jang IK et al. In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: a comparison with intravascular ultrasound. Ultrasound Med Biol 2005;31:1343-9. (Pubitemid 41434050)
13. Gonzalo N, Garcia-Garcia HM, Serruys PW, Commissaris KH, Bezerra H, Gobbens P et al. Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention 2009;5:224-32.
14. Gutierrez-Chico JL, Serruys PW, Girasis C, Garg S, Onuma Y, Brugaletta S et al. Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT. Int J Cardiovasc Imaging 2011 (Epub ahead of print).
15. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de WF et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006;333:1091.
16. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde JL. Imaging the vulnerable plaque. J Am Coll Cardiol 2011;57:1961-79.
17. Stone GW, Maehara A, Lansky AJ, de BB, Cristea E, Mintz GS et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-35.
18. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y et al. Assessment of coronary intima-media thickness by optical coherence tomography: comparison with intravascular ultrasound. Circ J 2005;69:903-7. (Pubitemid 41124256)
19. Yamaguchi T, Terashima M, Akasaka T, Hayashi T, Mizuno K, Muramatsu T et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008;101:562-7. (Pubitemid 351625080)
20. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-5.
21. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172-5.
22. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-7. (Pubitemid 43817856)
23. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755.e1-4.
24. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5. (Pubitemid 40470652)
25. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9. (Pubitemid 47313602)
26. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72. (Pubitemid 37243650)
27. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-61. (Pubitemid 41416300)
28. Fujii K, Masutani M, Okumura T, Kawasaki D, Akagami T, Ezumi A et al. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol 2008;52:787-8.
29. Sawada T, Shite J, Garcia-Garcia HM, Shinke T, Watanabe S, Otake H et al. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J 2008;29:1136-46. (Pubitemid 351844891)
30. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J 2009;30:1348-55.
31. Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol 2010;105:318-22.
32. Toutouzas K, Tsiamis E, Karanasos A, Drakopoulou M, Synetos A, Tsioufis C et al. Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter study. JACC Cardiovasc Interv 2010;3:507-14.
33. Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011;4:76-82.
34. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study. Circulation 2008;118:2368-73.
35. Fujii K, Kawasaki D, Masutani M, Okumura T, Akagami T, Sakoda T et al. OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. JACC Cardiovasc Imaging 2010;3:168-75.
36. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007;50:940-9. (Pubitemid 47313605)
37. Imola F, Mallus MT, Ramazzotti V, Manzoli A, Pappalardo A, Di GA et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention 2010;6: 575-81.
38. Gerber RT, Latib A, Ielasi A, Cosgrave J, Qasim A, Airoldi F et al. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc Interv 2009;74:348-56.
39. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998;19:1214-23. (Pubitemid 28362605)
40. Albiero R, Rau T, Schluter M, Di MC, Reimers B, Mathey DG et al. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 1997;96:2997-3005. (Pubitemid 27500101)
41. Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000;102:523-30. (Pubitemid 30639970)
42. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J 2010;31:1470-6.
43. Gutiérrez-Chico J, Wykrzykowska JJ, Nüesch E, van Geuns RJ, Koch K, Koolen JJ et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv 2012 (in press).
44. Gutiérrez-Chico JL, Regar E, Nüesch E, Okamura T, Wykrzykowska J, di Mario C et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents. Circulation 2011;124:612-23.
45. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. (Pubitemid 46717966)
46. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5. (Pubitemid 38222887)
47. Tanigawa J, Barlis P, di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 2007;3:128-36.
48. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-7. (Pubitemid 47343895)
49. Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 2008;1:475-84. (Pubitemid 351998679)
50. Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009;73:1033-7.
51. Gutiérrez-Chico J, van Geuns RJ, Koch K, Koolen J, Duckers HJ, Regar E et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomized trial balloon-first vs. stent first. EuroIntervention 2011;7:711-22.
52. Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin Med J (Engl) 2008;121:503-7. (Pubitemid 351479628)
53. Gutiérrez-Chico J, Jüni P, García-García HM, Regar E, Nüesch E, Borgia F et al. Long term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer. Am Heart J 2011;162: 922-31.
54. Miyoshi N, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. 6-month follow-up. Circ J 2010;74:903-8.
55. Inoue T, Shite J, Yoon J, Shinke T, Otake H, Sawada T et al. Optical coherence evaluation for everolimus-eluting stents at 8 months after implantation (Cooperative Study with Korea). Heart 2010;97:1379-84.
56. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T et al. Longterm follow-up of neointimal coverage of sirolimus-eluting stents - evaluation with optical coherence tomography. Circ J 2009;73:2300-7.
57. Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3: 531-9.
58. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 2011;123: 274-81.
59. Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv 2010;3: 367-75.
60. Guagliumi G, Sirbu V, Bezerra H, Biondi-Zoccai G, Fiocca L, Musumeci G et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. JACC Cardiovasc Interv 2010;3:680-7.
61. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
62. Serruys PW, Onuma Y, Ormiston JA, De Bruyne B, Regar E, Dudek D et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: 6-month clinical and imaging outcomes. Circulation 2010;122:2301-12.
63. Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T et al. Assessment by optical coherence tomography of stent struts across side branch. Comparison of bare-metal stents and drug-elution stents. Circ J 2010;75:106-12.
64. Gutierrez-Chico JL, van Geuns RJ, Regar E, van der Giessen WJ, Kelbaek H, Saunamaki K et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011;32:2454-63.
65. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Garcia-Garcia HM, Onuma Y et al. Relation between plaque type and dissections at the edges after stent implantation: An optical coherence tomography study. Int J Cardiol 2011;150:151-5.
66. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Onuma Y, Garcia-Garcia HM et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009;95: 1913-9.
67. Shin ES, Garcia-Garcia HM, Okamura T, Wykrzykowska JJ, Gonzalo N, Shen ZJ et al. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: a study with optical coherence tomography. J Invasive Cardiol 2010;22:435-9.
68. Viceconte N, Chan P, Ghilencea L, Lindsay A, Foin N, di Mario C. Frequency domain optical coherence tomography for guidance of coronary stenting. Int J Cardiol 2012 (Epub ahead of print).
69. Viceconte N, Tyczynski P, Ferrante G, Foin N, Chan P, Alegría-Barrero E et al. Immediate results of bifurcational stenting assessed with optical coherence tomography. Cathet Cardiovasc Intervent 2012 (in press).
70. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. J Am Med Assoc 2005;293:2126-30. (Pubitemid 40617065)
71. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, the SCAAR Study Group. Long-term outcomes with drug-eluting stents versus baremetal stents in Sweden. N Engl J Med 2007;356:1009-19. (Pubitemid 46376801)
72. Takano M, Yamamoto M, Mizuno M, Murakami D, Inami T, Kimata N et al. Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography. Circ Cardiovasc Interv 2010;3:476-83.
73. Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 2010;31:165-76.
74. Moore P, Barlis P, Spiro J, Ghimire G, Roughton M, Di MC et al. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv 2009;2: 437-44.
75. Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging 2010;3:76-84.
76. Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010;31:1792-801.
77. van Beusekom HM, Sorop O, van den HM, Onuma Y, Duncker DJ, Danser AH et al. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimus and tacrolimus-eluting stents. EuroIntervention 2010;6:117-25.
78. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008;94:566-70. (Pubitemid 351580126)
79. Choi H, Kim JS, Yoon D, Hong KS, Kim T, Kim B et al. Favorable neointimal coverage in everolimus-eluting stent at 9-months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2012 (Epub ahead of print).
80. Kim JS, Jang IK, Kim JS, Kim TH, Takano M, Kume T et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 2009;95:1907-12.
81. Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010;74:320-6.
82. Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y et al. Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation. Circ J 2009;73:1627-34.
83. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007;99:1033-8. (Pubitemid 46560470)
84. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 2008;51: 968-9. (Pubitemid 351282461)
85. Tian F, Chen YD, Sun ZJ, Chen L, Yuan F, Song XT et al. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography. Chin Med J (Engl) 2009;122:670-4.
86. Gutiérrez-Chico JL, Räber L, Regar E, Okamura T, di Mario C, van Es GA et al. Tissue coverage and neointimal hyperplasia in overlap vs. non-overlap segments of drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence tomography. JACC Cardiovasc Imaging 2012 (under review).
87. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van SG et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93.
88. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y et al. Appearance of Lipid-Laden intima and neovascularization after implantation of bare-metal stents: extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 2009;55:26-32.
89. Tanimoto S, Aoki J, Serruys PW, Regar E. Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography. EuroIntervention 2006;1:484.
90. Teramoto T, Ikeno F, Otake H, Lyons JK, van Beusekom HM, Fearon WF et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J 2010;74:1257-9.
91. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010;75:961-3.
92. Davlouros PA, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A et al. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study. Int J Cardiol (in press).
93. Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009;2:1240-47.
94. Davlouros PA, Mavronasiou E, Xanthopoulou I, Karantalis V, Tsigkas G, Hahalis G, Alexopoulos D. An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. Int J Cardiol (in press).
95. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A et al. Biolimus- eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008;372:1163-73.
96. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC et al. Paclitaxel- Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction. New England Journal of Medicine 2009;360:1946-59.
97. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE et al. Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents. New Engl J Med 2010;363:136-46.